WebSupporting: 1, Mentioning: 24 - Despite the known health and economic benefits of medications, nonadherence remains a significant, yet entirely preventable public health burden. Over decades, there have been numerous research studies evaluating health interventions and policy efforts aimed at improving adherence, yet no universal or … Web15 aug. 2024 · Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 166 , 1836–1841 (2006). Article PubMed Google Scholar
The association between medication non‐adherence and adverse …
Web25 sep. 2006 · Medication nonadherence is prevalent among patients with diabetes mellitus and is associated with adverse outcomes. Interventions are needed to … Web8 jan. 2015 · Medication adherence is an important determinant of outcomes in patients with chronic diseases. For those with diabetes, adherence to medications is associated with better control of intermediate risk factors (1–4), lower odds of hospitalization (3,5–7), lower health care costs (5,7–9), and lower mortality (3,7). syphilitic orchitis
A Longitudinal Study of Medication Nonadherence and Hospitalization ...
WebIn our study, the nonadherence rate was 37.9%, and another study showed that only a minority of patients with schizophrenia adhere to their medication in the first 2 months after discharge from first hospitalization in Finland. 33 Because neither Finland nor the People’s Republic of China have compulsory outpatient treatment, all patients discharged from … Web15 jan. 2008 · We investigated the temporal relationship between nonadherence and hospitalization risk using a daily measure of medication availability. Method: Our observational cohort included 1191 patients with schizophrenia (ICD-9 criteria) enrolled in Maine and New Hampshire Medicaid programs who initiated atypical antipsychotic … Web11 apr. 2024 · Standardisation of the metric measures used to estimate medication non-adherence and development of a streamlined approach to quantify costs is required. Prospero registration number: CRD42015027338. syphilitic optic neuropathy